A detailed history of Pacifica Partners Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Pacifica Partners Inc. holds 465 shares of LLY stock, worth $412,431. This represents 0.19% of its overall portfolio holdings.

Number of Shares
465
Previous 660 29.55%
Holding current value
$412,431
Previous $513,000 17.93%
% of portfolio
0.19%
Previous 0.23%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

SELL
$724.87 - $909.04 $141,349 - $177,262
-195 Reduced 29.55%
465 $421,000
Q1 2024

Apr 12, 2024

SELL
$592.2 - $792.28 $18,358 - $24,560
-31 Reduced 4.49%
660 $513,000
Q4 2023

Jan 05, 2024

BUY
$525.19 - $619.13 $89,282 - $105,252
170 Added 32.63%
691 $402,000
Q3 2023

Oct 10, 2023

BUY
$434.7 - $599.3 $217,350 - $299,650
500 Added 2380.95%
521 $279,000
Q4 2021

Jan 13, 2022

BUY
$224.85 - $279.04 $4,721 - $5,859
21 New
21 $5,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $843B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Pacifica Partners Inc. Portfolio

Follow Pacifica Partners Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacifica Partners Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacifica Partners Inc. with notifications on news.